Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

GALECTIN THERAPEUTICS INC

GALT · Nasdaq · CIK 0001133416 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

18 Form 4 transaction lines observed in the same window
8 sales · 10 option, withholding, award, gift or other lines

Last qualifying purchase2026-02-06 · ELDRED KARY · $810

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Jamil KhurramChief Medical Officer
○▼○▼○▼○▼○▼
Shlevin Harold H.Director
○▼○▼
Uihlein Richard EDirector,TenPercentOwner
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-02-06 · ELDRED KARY.

Recent Form 4 activity

6Purchases
66Sales
56Other Form 4 lines
37SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING8 sale line(s) · context only
OTHER10 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
9,206,832
Previous report
9,335,305
Avg daily volume
273,539
Days to cover
33.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-02-06ELDRED KARYPurchase (P)Common Stock300USD 2.70USD 810SEC filing ↗
2025-12-23FREEMAN KEVIN DPurchase (P)Common Stock5,500USD 3.55USD 19,525SEC filing ↗
2025-12-23FREEMAN KEVIN DPurchase (P)Common Stock5,500USD 3.55USD 19,525SEC filing ↗
2025-12-23FREEMAN KEVIN DPurchase (P)Common Stock5,500USD 3.55USD 19,525SEC filing ↗
2025-12-23ELDRED KARYPurchase (P)Common Stock700USD 3.73USD 2,611SEC filing ↗
2025-12-23ELDRED KARYPurchase (P)Common Stock700USD 3.73USD 2,611SEC filing ↗
2025-07-21ELDRED KARYPurchase (P)Common Stock1,000USD 2.93USD 2,930SEC filing ↗
2025-07-17FREEMAN KEVIN DPurchase (P)Common Stock5,000USD 2.90USD 14,500SEC filing ↗
2024-12-30Shlevin Harold H.Purchase (P)Common Stock6,500USD 1.16USD 7,540SEC filing ↗
2024-12-24Zordani Richard A. Jr.Purchase (P)Common Stock10,000USD 0.82USD 8,200SEC filing ↗
2024-12-24FREEMAN KEVIN DPurchase (P)Common Stock10,000USD 0.81USD 8,100SEC filing ↗
2024-12-24ELDRED KARYPurchase (P)Common Stock13,469USD 0.82USD 11,045SEC filing ↗
2024-10-23ELDRED KARYPurchase (P)Common Stock500USD 2.60USD 1,300SEC filing ↗
2024-10-17FREEMAN KEVIN DPurchase (P)Common Stock1,300USD 2.64USD 3,432SEC filing ↗
2024-10-16FREEMAN KEVIN DPurchase (P)Common Stock5,000USD 2.70USD 13,500SEC filing ↗

Form 4 evidence

128 transaction lines in the latest 365-day window; 345 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-31Uihlein Richard EOption exercise / conversion (M)Common Stock34,376,167USD 3.08USD 105,806,980SEC filing ↗
2026-07-14Jamil KhurramSale (S)Common Stock16,250USD 5.13USD 83,362SEC filing ↗
2026-07-14Jamil KhurramOption exercise / conversion (M)Common Stock16,250USD 3.04USD 49,400SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-31Uihlein Richard EOption exercise / conversion (M)Common Stock34,376,167USD 3.08USD 105,806,980SEC filing ↗
2026-07-14Jamil KhurramSale (S)Common Stock16,250USD 5.13USD 83,362SEC filing ↗
2026-07-14Jamil KhurramOption exercise / conversion (M)Common Stock16,250USD 3.04USD 49,400SEC filing ↗
2026-06-29Shlevin Harold H.Sale (S)Common Stock22,268USD 5.04USD 112,231SEC filing ↗
2026-06-29Shlevin Harold H.Option exercise / conversion (M)Common Stock22,268USD 1.23USD 27,390SEC filing ↗
2026-06-29Jamil KhurramSale (S)Common Stock47,467USD 5.04USD 239,234SEC filing ↗
2026-06-29Jamil KhurramOption exercise / conversion (M)Common Stock47,467USD 2.50USD 118,668SEC filing ↗
2026-06-26Shlevin Harold H.Sale (S)Common Stock7,732USD 5.00USD 38,660SEC filing ↗
2026-06-26Shlevin Harold H.Option exercise / conversion (M)Common Stock7,732USD 1.23USD 9,510SEC filing ↗
2026-06-26Jamil KhurramSale (S)Common Stock4,570USD 5.00USD 22,850SEC filing ↗
2026-06-26Jamil KhurramOption exercise / conversion (M)Common Stock4,570USD 2.37USD 10,814SEC filing ↗
2026-06-23Jamil KhurramSale (S)Common Stock7,557USD 3.14USD 23,729SEC filing ↗
2026-06-23Jamil KhurramOption exercise / conversion (M)Common Stock7,557USD 1.23USD 9,295SEC filing ↗
2026-05-26Jamil KhurramSale (S)Common Stock568USD 3.10USD 1,761SEC filing ↗
2026-05-26Jamil KhurramOption exercise / conversion (M)Common Stock568USD 1.23USD 699SEC filing ↗
2026-02-06ELDRED KARYPurchase (P)Common Stock300USD 2.70USD 810SEC filing ↗
2026-01-16Uihlein Richard EAward / grant (A)Common Stock13,158USD 3.04USD 40,000SEC filing ↗
2026-01-06LEWIS JOELSale (S)Common Stock37,698USD 3.58USD 134,959SEC filing ↗
2026-01-06Jamil KhurramSale (S)Common Stock21,446USD 3.65USD 78,278SEC filing ↗
2026-01-06CALLICUTT JACK WSale (S)Common Stock20,354USD 3.67USD 74,699SEC filing ↗
2026-01-05LEWIS JOELOther (—)Common Stock56,332USD 3.88USD 218,568SEC filing ↗
2026-01-05LEWIS JOELSale (S)Common Stock27,731USD 3.91USD 108,428SEC filing ↗
2026-01-05Jamil KhurramSale (S)Common stock25,499USD 3.90USD 99,446SEC filing ↗
2026-01-05CALLICUTT JACK WSale (S)Common Stock25,732USD 3.90USD 100,355SEC filing ↗
2026-01-02LEWIS JOELSale (S)Common Stock18,571USD 4.20USD 77,998SEC filing ↗
2026-01-02LEWIS JOELOption exercise / conversion (M)Common Stock84,000USD 0.00USD 0SEC filing ↗
2026-01-02Jamil KhurramSale (S)Common Stock13,055USD 4.20USD 54,831SEC filing ↗
2026-01-02Jamil KhurramOption exercise / conversion (M)Common Stock60,000USD 0.00USD 0SEC filing ↗
2026-01-02CALLICUTT JACK WSale (S)Common Stock13,914USD 4.20USD 58,439SEC filing ↗
2026-01-02CALLICUTT JACK WOption exercise / conversion (M)Common Stock60,000USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerGALT
CIK0001133416
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history345 transaction lines from 2020-01-09 to 2026-07-31
50 P purchase lines · 103 S sale lines · 192 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.